Predictive Genetic Testing and Consumer/Wellness Genomics Market: Global Industry Analysis and Forecast (2023-2029)

The Predictive Genetic Testing and Consumer/Wellness Genomics Market Size was valued at USD 5.74 Bn. In 2022 and the total Predictive Genetic Testing and Consumer/Wellness Genomics Market. revenue is growing by 14 % from 2023 to 2029, reaching nearly USD 14.36 Bn.

Predictive Genetic Testing and Consumer/Wellness Genomics Market Overview:

Predictive Genetic Testing and Consumer/Wellness Genomics both involve analyzing an individual's DNA to provide personalized information about health-related aspects. Predictive genetic testing focuses on disease risk and medical conditions, consumer genomics offers insights into broader wellness and lifestyle factors. Predictive Genetic Testing and Consumer/Wellness Genomics Market is experiencing rapid growth due to advancements in genomic technologies, increasing demand for personalized healthcare, and the rise of direct-to-consumer testing companies. Consumers' interest in ancestry, wellness, and lifestyle optimization has accelerated the demand for genetic testing services. Healthcare professionals' advocacy, a supportive regulatory environment, and collaborations with pharmaceutical companies have further boosted market expansion. As genetic testing becomes more accessible and affordable, its integration into employer wellness programs and medical practice is on the rise. The Predictive Genetic Testing and Consumer/Wellness Genomics Market shows promising prospects for continued expansion, offering personalized health insights to a broader population.

Predictive Genetic Testing and Consumer/Wellness Genomics Market Snapshot

Predictive Genetic Testing & Consumer/Wellness Genomics MarketTo know about the Research Methodology :- Request Free Sample Report

Predictive Genetic Testing and Consumer/Wellness Genomics Market Dynamics

Increasing Awareness and Demand for Genetic Testing Boosts Market Growth The increasing awareness and demand for personalized healthcare have become significant drivers in boosting the growth of the predictive genetic testing and consumer/wellness genomics market. People are becoming more aware of how genes influence health, therefore they are seeking personalized solutions based on their genetic structure. This growing awareness helps to a significant increase in the demand for predictive genetic testing services. Individuals are eager to understand genetic predispositions to certain diseases. The rise of personalized healthcare fuelled advancements in genomic technologies, making genetic testing more accessible and affordable and attracting more individuals to get tested. After understanding the genetic risk people make decisions about their lifestyle choices to improve their health condition. Healthcare providers and consumers alike realize the potential of using genetic information for preventive measures and personalized treatment plans. Both healthcare providers and consumers are realizing the potential of using genetic information for preventive measures and personalized treatment plans. Where treatments are customized based on a patient's genetic profile Integrating genetic data into healthcare practices allows for personalized medicine. This approach leads to better outcomes for patients and potentially reduces healthcare costs in the long run. For Instance, in November 2022, there were 76,326 current genetic tests on GTR worldwide. Where 76,083 (99.7%) tests were clinical and 243 (0.3%) were for research purposes. Of the 76,326 current tests, 37,289 (48.91%) belonged to laboratories in the US; 37,124 (99.56%) and 165 (0.44%) tests were for clinical and research purposes, respectively. In the US, 200 laboratories performed 37,124 current clinical tests on the interactive database; 29 laboratories performed whole exome sequencing (WES), and 17 laboratories performed whole genome sequencing (WGS).

Genetic Testing Purpose Category (%) in the year 2022

Predictive Genetic Testing & Consumer/Wellness Genomics Market Research and Drug Development in Genetic Testing Drives the Market growth. Research and drug development in genetic testing have become key drivers of growth for the Predictive Genetic Testing and Consumer/Wellness Genomics Market. As scientific understanding deepens and more genetic markers are discovered, the demand for predictive genetic testing surges, fuelling market expansion. Pharmaceutical companies recognize the value of genetic data in identifying new drug targets and stratifying patients for clinical trials. Collaborations between genetic testing companies and pharmaceutical firms lead to data-sharing agreements and joint research efforts, creating new revenue streams. Moreover, the emphasis on personalized medicine, enabled by genetic testing insights, reshapes healthcare practices, making genetic testing an integral part of treatment plans. This trend drives increased adoption and market growth. As regulatory bodies witness the clinical utility of genetic testing through research and drug development, they are likely to provide more supportive guidelines, simplifying market entry and fostering growth. Technological advancements, such as improved testing technologies and data analytics, enhance the accuracy and accessibility of genetic tests, attracting more consumers and healthcare providers to adopt these services. In this ecosystem, research and drug development not only advance medical knowledge but also create lucrative opportunities for the predictive genetic testing and consumer/wellness genomics market, driving its continued expansion.

Ethical and Privacy Concerns Restrain Predictive Market Growth

Ethical and privacy concerns are significant restraining factors that impede the growth of the predictive genetic testing and consumer/wellness genomics market. Consumers and healthcare providers alike have raised apprehensions about the potential misuse of sensitive genetic information. The fear of genetic discrimination by employers or insurers based on test results has led to hesitancy among individuals to undergo testing. Furthermore, the inadequate regulation and oversight of genetic testing services have contributed to privacy concerns. As genetic data contains intimate details about an individual's health and predispositions, data breaches or unauthorized access to this information could lead to severe privacy violations. The lack of clear ethical guidelines and standardized consent practices for genetic testing also hampers market growth. Uncertainty regarding how genetic data will be used and shared creates a sense of mistrust among potential consumers, deterring them from participating in such tests. Addressing these ethical and privacy concerns will be crucial for gaining public trust and promoting the widespread adoption of genetic testing. Implementing robust data protection measures, enhancing transparency in data handling practices, and establishing clear guidelines for ethical considerations are essential steps in mitigating these restraints and fostering the sustainable growth of the predictive genetic testing and consumer/wellness genomics market. Advancements in Genomic Technologies create lucrative growth opportunities for Market Growth. The Advancements in genomic technologies have significantly influenced the predictive genetic testing and consumer/wellness genomics market. The innovations made genetic testing more accessible, affordable, and informative to people. It also, allows individuals to gain insights into their genetic potential health risks. New genetic technologies, like next-generation sequencing, is significantly enhanced the speed and efficiency of analysing genetic data, resulting in increased accuracy and reliability of genetic testing. For Instance, Due to the development of the Personal Genome Service by 23andMe made it possible for consumers to order a genetic test online and get results in a matter of weeks. This service made genetic testing more accessible to consumers, and it is helped to increase awareness of the benefits of genetic testing. Additionally, improved data analysis techniques and artificial intelligence algorithms have revolutionized genomic data interpretation. These tools analyse vast amounts of genetic information, identifying meaningful patterns and associations that were previously difficult to detect. For Instance, GenoSense a company specializing in consumer genomics, the company used AI algorithms to analyse an individual's genetic data in combination with lifestyle and health information. On the basis of this analysis, the company provides personalized recommendations for diet, exercise, and lifestyle modifications to improve overall health and wellness. These All advancements in Genomic Technologies drive the growth of the Market. The Advancements in genomic technologies have significantly influenced the predictive genetic testing and consumer/wellness genomics market. The innovations made genetic testing more accessible, affordable, and informative to people. It also, allows individuals to gain insights into their genetic potential health risks. New genetic technologies, like next-generation sequencing, is significantly enhanced the speed and efficiency of analyzing genetic data, resulting in increased accuracy and reliability of genetic testing. For Instance, Due to the development of the Personal Genome Service by 23andMe made it possible for consumers to order a genetic test online and get results in a matter of weeks. This service made genetic testing more accessible to consumers, and it is helped to increase awareness of the benefits of genetic testing. Additionally, improved data analysis techniques and artificial intelligence algorithms have revolutionized genomic data interpretation. These tools analyze vast amounts of genetic information, identifying meaningful patterns and associations that were previously difficult to detect. For Instance, GenoSense a company specializing in consumer genomics, the company used AI algorithms to analyze an individual's genetic data in combination with lifestyle and health information. On the basis of this analysis, the company provides personalized recommendations for diet, exercise, and lifestyle modifications to improve overall health and wellness. These All advancements in Genomic Technologies drive the growth of the Market. Predictive Genetic Testing and Consumer/Wellness Genomics Market Segment Analysis: Based on the Test Type, Predictive testing dominates the test type segment of the Market in the year 2022. Predictive testing is a genetic testing method that identifies genetic mutations associated with a higher risk of developing certain diseases. This method offers valuable insights into health and disease predisposition, enabling individuals to make informed lifestyle choices, undergo regular screenings, and implement preventive measures. The medical benefits of predictive testing include improved health outcomes and potentially saving lives. However, it is crucial to approach predictive testing cautiously and receive adequate genetic counselling to fully understand its implications. Ethical and privacy concerns arise, but when used responsibly, predictive genetic testing can empower individuals to take charge of their health and well-being. The combination of medical benefits, growing consumer awareness, technological advancements, and the rise of direct-to-consumer testing has propelled predictive testing to dominate the test type segment in the Market.

Predictive Genetic Testing and Consumer/Wellness Genomics Market by Test Type in the year 2022(%)

Predictive Genetic Testing & Consumer/Wellness Genomics Market Based on the Setting Type, Direct-to-consumer (DTC) testing dominates the setting type segment of the predictive genetic testing and consumer/wellness genomics market in the year 2022.DTC testing allows consumers to access genetic testing kits directly without the need for a healthcare provider's prescription. This convenience significantly expanded the reach of genetic testing to a broader consumer base. DTC testing offers consumers greater control over their genetic data and privacy, as they can choose which genetic information they want to share and with whom. This control appeals to many consumers who are concerned about the privacy implications of sharing sensitive genetic information. DTC testing has played a crucial role in expanding the overall Predictive Genetic Testing and Consumer/Wellness Genomics Market. By making genetic testing more accessible and consumer-friendly, DTC companies have attracted a larger pool of customers.

Predictive Genetic Testing and Consumer/Wellness Genomics Market by Setting Type in the year 2022 (%)

Predictive Genetic Testing & Consumer/Wellness Genomics Market

Regional Insight

The North American region dominates the market for Market in the year 2022. Due to the presence of multiple firms based in the United States, North America dominated the industry in terms of revenue. These companies have several patents in the areas of predictive testing and wellness genomics. Participants in this market are pursuing several growth efforts to maintain their respective market share and contribute to increased revenue generation in the region. Increasing awareness of genetic disorders in the region, the increasing demand for personalized medicine, and the availability of a large number of DTC genetic testing companies. The United States has a positive regulatory framework, a factor allowing genetic testing services to flourish and become more accessible to consumers. This helps to ground-breaking discoveries and collaboration between scientists, healthcare professionals, and industry experts. Furthermore, the aging population, technological improvements in the genetic testing area, an increase in the instances of chronic diseases as a result of this, and rising cancer incidences are all contributing to the growth of the North American genetic testing market.

Predictive Genetic Testing and Consumer/Wellness Genomics Market Scope: Inquire Before Buying

Global Predictive Genetic Testing and Consumer/Wellness Genomics Market
Report Coverage Details
Base Year: 2022 Forecast Period: 2023-2029
Historical Data: 2018 to 2022 Market Size in 2022: US $ 5.74 Bn.
Forecast Period 2023 to 2029 CAGR: 14% Market Size in 2029: US $ 14.36 Bn.
Segments Covered: by Test Type Predictive Testing Genetic Susceptibility Test   Predictive Diagnostics   Population Screening Consumer Genomics Wellness Genomics    Nutria Genetics    Skin & Metabolism Genetics    Others
by Setting Type Clinic Setting Direct-to-consumer Setting Hospital Setting
by Application Cancer Cardiovascular diseases Single-gene disorder Others

Predictive Genetic Testing and Consumer/Wellness Genomics Market by Region

North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria, Turkey, Russia and Rest of Europe) Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina, Columbia and Rest of South America)

Predictive Genetic Testing and Consumer/Wellness Genomics Market Key Players

1. F. Hoffmann-La Roche Ltd. 2. Abbott Laboratories 3. Thermo Fisher Scientific, Inc. 4. Agilent Technologies, Inc. 5. BGI 6. 23andMe, Inc. 7. Bio-Rad Laboratories, Inc. 8. Illumina, Inc. 9. QIAGEN 10. Positive Biosciences, Ltd. 11. Myriad Genetics, Inc. 12. Siemens 13. Pathway Genomics 14. ARUP Laboratories 15. EasyDNA 16. Gene by Gene 17. Cooper Surgical, Inc.

Frequently Asked Questions:

1] What segments are covered in the Global Predictive Genetic Testing and Consumer/Wellness Genomics Market report? Ans. The segments covered in the Predictive Genetic Testing and Consumer/Wellness Genomics Market report are based on Test Type, setting Type, Application, and Regions. 2] Which region is expected to hold the highest share in the Global Predictive Genetic Testing and Consumer/Wellness Genomics Market? Ans. The North American region is expected to hold the highest share of the Predictive Genetic Testing and Consumer/Wellness Genomics Market. 3] What was the market size of the Global Market by 2022? Ans. The market size of the Predictive Genetic Testing and Consumer/Wellness Genomics Market by 2022 is expected to reach US$ 5.74 Bn. 4] What is the forecast period for the Global Market? Ans. The forecast period for the Market is 2023-2029. 5] What is the market size of the Global Market in 2029? Ans. The market size of the Market in 2029 is valued at US$ 14.36 Bn.
1. Predictive Genetic Testing and Consumer/Wellness Genomics Market: Research Methodology 2. Predictive Genetic Testing and Consumer/Wellness Genomics Market: Executive Summary 3. Predictive Genetic Testing and Consumer/Wellness Genomics Market: Competitive Landscape 3.1. MMR Competition Matrix 3.2. Competitive Landscape 3.3. Key Players Benchmarking 3.4. Market Structure 3.4.1. Market Leaders 3.4.2. Market Followers 3.4.3. Emerging Players 3.5. Consolidation of the Market 4. Predictive Genetic Testing and Consumer/Wellness Genomics Market: Dynamics 4.1. Market Trends by Region 4.1.1. North America 4.1.2. Europe 4.1.3. Asia Pacific 4.1.4. Middle East and Africa 4.1.5. South America 4.2. Market Drivers by Region 4.2.1. North America 4.2.2. Europe 4.2.3. Asia Pacific 4.2.4. Middle East and Africa 4.2.5. South America 4.3. Market Restraints 4.4. Market Opportunities 4.5. Market Challenges 4.6. PORTER’s Five Forces Analysis 4.7. PESTLE Analysis 4.8. Value Chain Analysis 4.9. Regulatory Landscape by Region 4.9.1. North America 4.9.2. Europe 4.9.3. Asia Pacific 4.9.4. Middle East and Africa 4.9.5. South America 5. Predictive Genetic Testing and Consumer/Wellness Genomics Market Size and Forecast by Segments (by Value USD) 5.1. Predictive Genetic Testing and Consumer/Wellness Genomics Market Size and Forecast, by Test Type (2022-2029) 5.1.1. Predictive Testing 5.1.2. Consumer Genomics 5.1.3. Wellness Genomics 5.2. Predictive Genetic Testing and Consumer/Wellness Genomics Market Size and Forecast, by Setting Type (2022-2029) 5.2.1. Clinic Setting 5.2.2. Direct-to-consumer Setting 5.2.3. Hospital Setting 5.3. Predictive Genetic Testing and Consumer/Wellness Genomics Market Size and Forecast, by Application (2022-2029) 5.3.1. Cancer 5.3.2. Cardiovascular diseases 5.3.3. Single-gene disorders 5.3.4. Others 5.4. Predictive Genetic Testing and Consumer/Wellness Genomics Market Size and Forecast, by Region (2022-2029) 5.4.1. North America 5.4.2. Europe 5.4.3. Asia Pacific 5.4.4. Middle East and Africa 5.4.5. South America 6. North America Predictive Genetic Testing and Consumer/Wellness Genomics Market Size and Forecast (by Value USD) 6.1. North America Predictive Genetic Testing and Consumer/Wellness Genomics Market Size and Forecast, by Test Type (2022-2029) 6.1.1. Predictive Testing 6.1.2. Consumer Genomics 6.1.3. Wellness Genomics 6.2. North America Predictive Genetic Testing and Consumer/Wellness Genomics Market Size and Forecast, by Setting Type (2022-2029) 6.2.1. Clinic Setting 6.2.2. Direct-to-consumer Setting 6.2.3. Hospital Setting 6.3. North America Predictive Genetic Testing and Consumer/Wellness Genomics Market Size and Forecast, by Application (2022-2029) 6.3.1. Cancer 6.3.2. Cardiovascular diseases 6.3.3. Single-gene disorders 6.3.4. Others 6.4. North America Predictive Genetic Testing and Consumer/Wellness Genomics Market Size and Forecast, by Country (2022-2029) 6.4.1. United States 6.4.2. Canada 6.4.3. Mexico 7. Europe Predictive Genetic Testing and Consumer/Wellness Genomics Market Size and Forecast (by Value USD) 7.1. Europe Predictive Genetic Testing and Consumer/Wellness Genomics Market Size and Forecast, by Test Type (2022-2029) 7.1.1. Predictive Testing 7.1.2. Consumer Genomics 7.1.3. Wellness Genomics 7.2. Europe Predictive Genetic Testing and Consumer/Wellness Genomics Market Size and Forecast, by Setting Type (2022-2029) 7.2.1. Clinic Setting 7.2.2. Direct-to-consumer Setting 7.2.3. Hospital Setting 7.3. Europe Predictive Genetic Testing and Consumer/Wellness Genomics Market Size and Forecast, by Application (2022-2029) 7.3.1. Cancer 7.3.2. Cardiovascular diseases 7.3.3. Single-gene disorders 7.3.4. Others 7.4. Europe Predictive Genetic Testing and Consumer/Wellness Genomics Market Size and Forecast, by Country (2022-2029) 7.4.1. UK 7.4.2. France 7.4.3. Germany 7.4.4. Italy 7.4.5. Spain 7.4.6. Sweden 7.4.7. Austria 7.4.8. Rest of Europe 8. Asia Pacific Predictive Genetic Testing and Consumer/Wellness Genomics Market Size and Forecast (by Value USD) 8.1. Asia Pacific Predictive Genetic Testing and Consumer/Wellness Genomics Market Size and Forecast, by Test Type (2022-2029) 8.1.1. Predictive Testing 8.1.2. Consumer Genomics 8.1.3. Wellness Genomics 8.2. Asia Pacific Predictive Genetic Testing and Consumer/Wellness Genomics Market Size and Forecast, by Setting Type (2022-2029) 8.2.1. Clinic Setting 8.2.2. Direct-to-consumer Setting 8.2.3. Hospital Setting 8.3. Asia Pacific Predictive Genetic Testing and Consumer/Wellness Genomics Market Size and Forecast, by Application (2022-2029) 8.3.1. Cancer 8.3.2. Cardiovascular diseases 8.3.3. Single-gene disorders 8.3.4. Others 8.4. Asia Pacific Predictive Genetic Testing and Consumer/Wellness Genomics Market Size and Forecast, by Country (2022-2029) 8.4.1. China 8.4.2. S Korea 8.4.3. Japan 8.4.4. India 8.4.5. Australia 8.4.6. Indonesia 8.4.7. Malaysia 8.4.8. Vietnam 8.4.9. Taiwan 8.4.10. Bangladesh 8.4.11. Pakistan 8.4.12. Rest of Asia Pacific 9. Middle East and Africa Predictive Genetic Testing and Consumer/Wellness Genomics Market Size and Forecast (by Value USD) 9.1. Middle East and Africa Predictive Genetic Testing and Consumer/Wellness Genomics Market Size and Forecast, by Test Type (2022-2029) 9.1.1. Predictive Testing 9.1.2. Consumer Genomics 9.1.3. Wellness Genomics 9.2. Middle East and Africa Predictive Genetic Testing and Consumer/Wellness Genomics Market Size and Forecast, by Setting Type (2022-2029) 9.2.1. Clinic Setting 9.2.2. Direct-to-consumer Setting 9.2.3. Hospital Setting 9.3. Middle East and Africa Predictive Genetic Testing and Consumer/Wellness Genomics Market Size and Forecast, by Application (2022-2029) 9.3.1. Cancer 9.3.2. Cardiovascular diseases 9.3.3. Single-gene disorders 9.3.4. Others 9.4. Middle East and Africa Predictive Genetic Testing and Consumer/Wellness Genomics Market Size and Forecast, by Country (2022-2029) 9.4.1. South Africa 9.4.2. GCC 9.4.3. Egypt 9.4.4. Nigeria 9.4.5. Rest of ME&A 10. South America Predictive Genetic Testing and Consumer/Wellness Genomics Market Size and Forecast (by Value USD) 10.1. South America Predictive Genetic Testing and Consumer/Wellness Genomics Market Size and Forecast, by Test Type (2022-2029) 10.1.1. Predictive Testing 10.1.2. Consumer Genomics 10.1.3. Wellness Genomics 10.2. South America Predictive Genetic Testing and Consumer/Wellness Genomics Market Size and Forecast, by Setting Type (2022-2029) 10.2.1. Clinic Setting 10.2.2. Direct-to-consumer Setting 10.2.3. Hospital Setting 10.3. South America Predictive Genetic Testing and Consumer/Wellness Genomics Market Size and Forecast, by Application (2022-2029) 10.3.1. Cancer 10.3.2. Cardiovascular diseases 10.3.3. Single-gene disorders 10.3.4. Others 10.4. South America Predictive Genetic Testing and Consumer/Wellness Genomics Market Size and Forecast, by Country (2022-2029) 10.4.1. Brazil 10.4.2. Argentina 10.4.3. Rest of South America 11. Company Profile: Key players 11.1. F. Hoffmann-La Roche Ltd. 11.1.1. Company Overview 11.1.2. Financial Overview 11.1.3. Business Portfolio 11.1.4. SWOT Analysis 11.1.5. Business Strategy 11.1.6. Recent Developments 11.2. Abbott Laboratories 11.3. Thermo Fisher Scientific, Inc. 11.4. Agilent Technologies, Inc. 11.5. BGI 11.6. 23andMe, Inc. 11.7. Bio-Rad Laboratories, Inc. 11.8. Illumina, Inc. 11.9. QIAGEN 11.10. Positive Biosciences, Ltd. 11.11. Myriad Genetics, Inc. 11.12. Siemens 11.13. Pathway Genomics 11.14. ARUP Laboratories 11.15. EasyDNA 11.16. Gene by Gene 11.17. Cooper Surgical, Inc. 12. Key Findings 13. Industry Recommendation

About This Report

Report ID 105070
Category Information Technology & Telecommunication
Published Date Aug 2023
Updated Date
  • INQUIRE BEFORE BUYING